miR-361-5p通过调解SLPI/ NF-κB信号通路来调节急性感染性内心炎
Hua Li1,2,3,4, Yaxiong Li1,2,3,4, Shen Han1,2,3,4
1Department of Cardiovascular Surgery, Yan'an Hospital Affiliated to Kunming Medical University, No.245 Renmin East Road, Kunming, 650051 Yunnan China.
Cytotechnology
|August 25, 2025
概括
通过增加分泌白细胞蛋白酶抑制剂 (SLPI) 和抑制NF-κB通路,降低miR-361-5p对急性传染性内心炎 (AIE) 的保护作用. 这一发现为AIE治疗提供了新的治疗策略.
科学领域:
- 心血管生物学
- 分子医学
- 传染性疾病
背景情况:
- 急性传染性内心炎 (AIE) 涉及内心炎症和植被形成,通常与金黄色葡萄球菌 (SA) 感染有关.
- 微RNA-361-5p (miR-361-5p) 和分泌白细胞蛋白酶抑制剂 (SLPI) 在AIE病变发生过程中的具体作用在很大程度上尚未确定.
- 肺炎感染和缺氧是AIE发展的关键因素,影响心脏细胞和功能.
研究的目的:
- 阐明 miR-361-5p 和 SLPI 在 Staphylococcus aureus 引起的急性感染性内心炎中的功能作用和分子机制.
- 研究miR- 361-5p与SLPI之间的相互作用以及它们对心脏细胞活力,细胞亡和炎症反应的联合作用.
- 在已建立的AIE模型中评估调节miR-361-5p水平的治疗潜力.
主要方法:
- 使用受低氧和SA感染的AC16细胞建立AIE细胞模型,以及AIE大鼠模型.
- 双露西法酶测定证实了miR-361-5p和SLPI之间的向相互作用.
- 定量评估包括RT-qPCR,西部抹血,CCK-8,流细胞测量,ELISA,H&E染色和TUNEL染色以分析分子和细胞变化.
主要成果:
- 在AIE模型中,miR-361-5p是上调的,而SLPI是下调的;miR-361-5p直接针对SLPI.
- 在体外,miR- 361-5p促进了细胞亡和炎症 (CK- MB,cTnT,IL- 1β,TNF- α的升高) 并激活了NF- kB p65信号,而SLPI过度表达或miR- 361-5p倒置则逆转了这些效应.
- 在体内,miR-361-5p降低了AIE大鼠的膜植被,心肌亡和心脏损伤标志物.
结论:
- 通过上调SLPI和抑制NF-κB p65信号通路,对miR-361-5p的下调具有保护作用.
- miR-361-5p/SLPI轴代表了AIE病变的关键调节机制.
- 针对miR-361-5p为治疗急性传染性内心炎提供了一个有前途的治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
Endocarditis I: Introduction
26
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
26
Endocarditis III: Medical Management
17
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
17
Endocarditis IV: Nursing Management
27
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
27
Endocarditis II: Clinical Features of Infective Endocarditis
25
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
25
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K


